The department has categorized such women under those with high risk pregnancies who are anaemic, suffering from high blood pressure, diabetes, kidney disease, obesity and HIV/AIDS. The department officials said that all the symptoms could lead to high risk of mortality during pregnancies.

In July, the health department had launched Kushal Mangal Karyakram (KMK) as an effort to achieve the millennium development goal of reducing MMR. Under the new scheme, the health department identifies high risk pregnancies. These are such pregnancies which turn into mortality and add up to maternal mortality ratio.

According to the health department figures, the state's MMR is 208 deaths over one lakh deliveries due to complications. As per the millennium development goal, MMR should be brought down to 181 deaths over one lakh deliveries.

Recently, the health department reviewed KMK. National Health Mission (NHM) director Navin Jain said that they identify high risk pregnancies and provide treatment to such women accordingly through trained healthcare staff.

The health department claimed that out of total pregnancies, it is estimated that 10% of pregnancies develop complications and they are called high risk pregnancies. The high risk pregnancy risks the life of mother or the foetus.Every year 19 lakh women give birth to babies in the state. But, out of a total of 19 lakh deliveries, 1.9 lakh pregnancies are high risk and they should be addressed with special attention.

The KMK has been launched with an aim to address 1.9 lakh pregnancies every year, which are at high risk.

The 10,895 identified high risk pregnancies in the past four months were referred to higher centres as per the need. Also, the healthcare staff conducted a follow-up of such pregnancies and monitored them. Meanwhile, the doctors encouraged the women with high risk pregnancies for institutional deliveries.

Subscribe ETHealthworld Newsletter

Lyrica, known generically as pregabalin, was originally developed for epilepsy but further research showed it could also help patients suffering from neuropathic pain, which soon became its main market.

With this acquisition, Nephroplus will further strengthen its servicing capacity as the dominant dialysis centre network and will have a presence in 18 states of India with 176 centers across 97 cities.